| SAHA shows preferential cytotoxicity in mutant p53 cancer cells by destabilizing mutant p53 through inhibition of the HDAC6-Hsp90 chaperone axis D Li, ND Marchenko, UM Moll Cell Death & Differentiation 18 (12), 1904-1913, 2011 | 357 | 2011 |
| Corrigendum: Improving survival by exploiting tumour dependence on stabilized mutant p53 for treatment EM Alexandrova, AR Yallowitz, D Li, S Xu, R Schulz, DA Proia, G Lozano, ... Nature 527 (7578), 398-398, 2015 | 343* | 2015 |
| Improving survival by exploiting tumour dependence on stabilized mutant p53 for treatment EM Alexandrova, AR Yallowitz, D Li, S Xu, R Schulz, DA Proia, G Lozano, ... Nature 523 (7560), 352-356, 2015 | 343 | 2015 |
| Functional inactivation of endogenous MDM2 and CHIP by HSP90 causes aberrant stabilization of mutant p53 in human cancer cells D Li, ND Marchenko, R Schulz, V Fischer, T Velasco-Hernandez, F Talos, ... Molecular Cancer Research 9 (5), 577-588, 2011 | 317 | 2011 |
| Stress-mediated nuclear stabilization of p53 is regulated by ubiquitination and importin-α3 binding ND Marchenko, W Hanel, D Li, K Becker, N Reich, UM Moll Cell Death & Differentiation 17 (2), 255-267, 2010 | 128 | 2010 |
| A gain-of-function mutant p53–HSF1 feed forward circuit governs adaptation of cancer cells to proteotoxic stress D Li, A Yallowitz, L Ozog, N Marchenko Cell death & disease 5 (4), e1194, 2014 | 98 | 2014 |
| The TCA cycle transferase DLST is important for MYC-mediated leukemogenesis. NM Anderson, D Li, HL Peng, FJ Laroche, MR Mansour, E Gjini, M Aioub, ... Leukemia, 2016 | 50 | 2016 |
| Mutant p53 amplifies epidermal growth factor receptor family signaling to promote mammary tumorigenesis AR Yallowitz, D Li, A Lobko, D Mott, A Nemajerova, N Marchenko Molecular Cancer Research 13 (4), 743-754, 2015 | 42 | 2015 |
| ErbB2 inhibition by lapatinib promotes degradation of mutant p53 protein in cancer cells. D Li, ND Marchenko Oncotarget 8 (4), 5823, 2017 | 23 | 2017 |
| CK2 inhibitor CX-4945 destabilizes NOTCH1 and synergizes with JQ1 against human T-acute lymphoblastic leukemic cells H Lian, D Li, Y Zhou, E Landesman-Bollag, G Zhang, NM Anderson, ... Haematologica 102 (1), e17-e21, 2017 | 19 | 2017 |
| Detection of Experimental and Clinical Immune Complexes by Measuring SHIP-1 Recruitment to the Inhibitory FcγRIIB RJ Stopforth, RJ Oldham, AL Tutt, P Duriez, HTC Chan, BF Binkowski, ... The Journal of Immunology, ji1700832, 2018 | 10 | 2018 |
| The multifaceted role of protein kinase CK2 in high-risk acute lymphoblastic leukemia Y Zhou, H Lian, N Shen, S Korm, AKP Lam, O Layton, LN Huiting, D Li, ... Haematologica, 2020 | 3 | 2020 |
